Shanghai, China

3rd November 2017

Register Now

 

All PhUSE Single Day Events are FREE to members, to become a member click here.

Registrations per company are limited to 20% of maximum attendance.

 

Theme:

Submission Readiness and TA Standards: Theory, Perspectives and Practice

 

Description:

With the requirements of implementation of data standards and the rejection process released by the FDA, preparing and ensuring a successful submission is a big challenge and requires thoughtful strategy planning and oversight. This event will focus on the understanding and discussion of agency requirements and expectations, submission packs, key deliverables, implementations of TA standards analysis and reporting, and other forward-thinking considerations. We will hear from experts from pharmaceutical companies and CROs, who will share their knowledge, experience and thoughts regarding updated processes, innovative technology, examples and case studies for collecting, analysing and submitting TA-specific trial data, issues impacting future submissions and TA specific application and implementation.   

 

Location:

Novartis Campus, Shanghai

 

Agenda:

TimePresentation Presenter
8.30 - 9.00am Registration  
9.00 - 9.05am Welcome Peng Wan, MSD &
Jingwei Gao, Boehringer Ingelheim
9.05 - 9.10am Opening Remarks Wei Chen,
Novartis
9.10 - 9.40am China CFDA Data Submission Regulatory Requirements and Updates CFDA CDE Invited Speaker
Yazhong Deng, TrustCRO
9.40 - 10.05am New CFDA Regulations and Clinical Data Management Report and DM Position in MRCT Anita Shen,
Janssen
10.05 - 10.30am e-Data Submission Overview in the US/EU/Japan/China Eason Yang,
Novartis
10.30 - 10.50am Morning Break  
10.50 - 11.15am Study Data Reviewer's Guide (SDRG) Automation Using R Markdown Qiang Wang,
dMed
11.15 - 11.40am Legacy Study Submission Components Review – Step-by-Step Chao Wang,
FMD K&L
11.40 - 12.10pm  Experiences in Preparing OSI Deliverables for FDA Submission Mina Chen,
Roche
12.10 - 1.30pm Lunch  
1.30 - 2.00pm Statistical Evaluations in Oncology Trials Yuan Geng,
Boehringer Ingelheim
2.00 - 2.30pm Statistical Programming Analysis Considerations for Oncology Studies: A Phase III Trial of PD-1 on NSCLC Patients Jianling Ren,
Hengrui
2.30 - 3.00pm

Programming Practice in Oncology Studies with RECIST 1.1 and irRC

Liang Guo,
FMD K&L
3.00 - 3.20pm Afternoon Break  
3.20 - 3.50pm Project Standard for Hematology Studies Eric Huang,
Amgen
3.50 - 4.15pm Time to Recurrent Composite Endpoint Yu Ruo,
Novartis
4.15 - 4.45pm Adaptive SAS Programming for Adaptive Submission Needs Hui Liu,
MSD
4.45 - 5.15pm Introduction to SAS Grid for Consideration Quting Zhang,
PPD
5.15 - 5.30pm     Closing Remarks  

Catering and refreshments will be provided throughout the day.

 

SDE Chairs:

Peng Wan, MSD

Jingwei Gao, Boehringer Ingelheim

If you have any questions, or require any information, please contact the SDE Co-Chair.

 

Sponsors:

      

 

     

If you are interested in sponsoring this event, click here.

 

Hotels:

To follow.

 

How do I join the PhUSE Society?

There are two easy ways to join PhUSE:

1. Click through to the on-line registration website by clicking here.

2. Contact office@phuse.eu for multiple membership applications or for invoicing arrangements.

Thinking of joining PhUSE?

Already a member but not sure how you can benefit?

PhUSE is an expanding, global society with a membership of more than 8,000 clinical data scientists. It requires a large pool of resources to help with its running so offers many opportunities for members to become involved. Whether it’s chairing a conference, presenting at an event, leading a working group or contributing to the quarterly newsletter, we are always keen to hear from volunteers.

Find Out More